– By GF Value
The stock of Sarepta Therapeutics (NAS:SRPT, 30-year Financials) is estimated to be possible value trap, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus’ estimate of the fair value at which the stock should be traded….

Click here to view the original article.